Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit.
Publication
, Journal Article
Brendler, CB; Cleeve, LK; Anderson, EE; Paulson, DF
Published in: J Urol
December 1980
A total of 125 patients underwent limited staging lymphadenectomy for adenocarcinoma of the prostate. Of these patients 19 per cent with clinical stage B1 disease, 52 per cent with clinical stage B2 disease and 59 per cent with clinical stages C disease had positive nodes. There was 1 death secondary to myocardial infarction and postoperative complications occurred in 7.2 per cent of the 125 patients. Limited staging pelvic node dissection provides information regarding nodal dissection similar to that identified after more extensive dissection and it can be accomplished with little morbidity.
Duke Scholars
Published In
J Urol
DOI
ISSN
0022-5347
Publication Date
December 1980
Volume
124
Issue
6
Start / End Page
849 / 850
Location
United States
Related Subject Headings
- Urology & Nephrology
- Risk
- Prostatic Neoplasms
- Pelvis
- Neoplasm Staging
- Male
- Lymphatic Metastasis
- Lymph Node Excision
- Humans
- Adenocarcinoma
Citation
APA
Chicago
ICMJE
MLA
NLM
Brendler, C. B., Cleeve, L. K., Anderson, E. E., & Paulson, D. F. (1980). Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit. J Urol, 124(6), 849–850. https://doi.org/10.1016/s0022-5347(17)55696-7
Brendler, C. B., L. K. Cleeve, E. E. Anderson, and D. F. Paulson. “Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit.” J Urol 124, no. 6 (December 1980): 849–50. https://doi.org/10.1016/s0022-5347(17)55696-7.
Brendler CB, Cleeve LK, Anderson EE, Paulson DF. Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit. J Urol. 1980 Dec;124(6):849–50.
Brendler, C. B., et al. “Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit.” J Urol, vol. 124, no. 6, Dec. 1980, pp. 849–50. Pubmed, doi:10.1016/s0022-5347(17)55696-7.
Brendler CB, Cleeve LK, Anderson EE, Paulson DF. Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit. J Urol. 1980 Dec;124(6):849–850.
Published In
J Urol
DOI
ISSN
0022-5347
Publication Date
December 1980
Volume
124
Issue
6
Start / End Page
849 / 850
Location
United States
Related Subject Headings
- Urology & Nephrology
- Risk
- Prostatic Neoplasms
- Pelvis
- Neoplasm Staging
- Male
- Lymphatic Metastasis
- Lymph Node Excision
- Humans
- Adenocarcinoma